Novel Insight into Ferroptosis in Kidney Diseases

Background: Various kidney diseases such as acute kidney injury, chronic kidney disease, polycystic kidney disease, renal cancer, and kidney stones, are an important part of the global burden, bringing a huge economic burden to people around the world. Ferroptosis is a type of nonapoptotic iron-dependent cell death caused by the excess of iron-dependent lipid peroxides and accompanied by abnormal iron metabolism and oxidative stress. Over the past few decades, several studies have shown that ferroptosis is associated with many types of kidney diseases. Studying the mechanism of ferroptosis and related agonists and inhibitors may provide new ideas and directions for the treatment of various kidney diseases. Summary: In this review, we discuss the differences between ferroptosis and other types of cell death such as apoptosis, necroptosis, pyroptosis, cuprotosis, pathophysiological features of the kidney, and ferroptosis-induced kidney injury. We also provide an overview of the molecular mechanisms involved in ferroptosis and events that lead to ferroptosis. Furthermore, we summarize the possible clinical applications of this mechanism among various kidney diseases. Key Message: The current research suggests that future therapeutic efforts to treat kidney ailments would benefit from a focus on ferroptosis.

[1]  Xubao Shi,et al.  A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer , 2022, Frontiers in Oncology.

[2]  Z. Massy,et al.  Vascular calcification in chronic kidney disease: contribution of ferroptosis? , 2022, Kidney international.

[3]  A. Alli,et al.  Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis. , 2022, Clinical immunology.

[4]  W. Sun,et al.  CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma , 2022, BMC Cancer.

[5]  Weitao Hu,et al.  Identification of hub ferroptosis-related genes and immune infiltration in lupus nephritis using bioinformatics , 2022, Scientific Reports.

[6]  Zhaoxin Tang,et al.  Asiatic acid alleviates LPS-induced acute kidney injury in broilers by inhibiting oxidative stress and ferroptosis via activation of the Nrf2 pathway. , 2022, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  Hailin Yin,et al.  Ferroptosis-related gene signature predicts prognosis in kidney renal papillary cell carcinoma , 2022, Frontiers in Oncology.

[8]  Lei Wang,et al.  Energy-Stress-Mediated AMPK Activation Promotes GPX4-Dependent Ferroptosis through the JAK2/STAT3/P53 Axis in Renal Cancer , 2022, Oxidative medicine and cellular longevity.

[9]  Hongjuan Zhao,et al.  ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma , 2022, Cancer & Metabolism.

[10]  Anwen Shao,et al.  Ferroptosis in glioma treatment: Current situation, prospects and drug applications , 2022, Frontiers in Oncology.

[11]  Xiuheng Liu,et al.  Upregulation of Metallothionein 1 G (MT1G) Negatively Regulates Ferroptosis in Clear Cell Renal Cell Carcinoma by Reducing Glutathione Consumption , 2022, Journal of oncology.

[12]  Weihua Gan,et al.  Mitochondrial Targeted Antioxidant SKQ1 Ameliorates Acute Kidney Injury by Inhibiting Ferroptosis , 2022, Oxidative medicine and cellular longevity.

[13]  M. Kojima,et al.  Dirty necrosis in renal cell carcinoma is associated with NETosis and systemic inflammation , 2022, Cancer medicine.

[14]  Y. Xun,et al.  CAV1 alleviated CaOx stones formation via suppressing autophagy-dependent ferroptosis , 2022, PeerJ.

[15]  S. Bornstein,et al.  Gasdermin D-deficient mice are hypersensitive to acute kidney injury , 2022, Cell Death & Disease.

[16]  Z. Ni,et al.  Downregulation of PPARα mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells , 2022, International journal of biological sciences.

[17]  Quentin Liu,et al.  Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma , 2022, Apoptosis.

[18]  Zhiyuan Chen,et al.  MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway , 2022, Oxidative medicine and cellular longevity.

[19]  Cheng Yang,et al.  ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC , 2022, Frontiers in Oncology.

[20]  Yong-gui Wu,et al.  Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis-Mediated Ferroptosis , 2022, Oxidative medicine and cellular longevity.

[21]  Christopher J. Greene,et al.  Iron accumulation typifies renal cell carcinoma tumorigenesis but abates with pathological progression, sarcomatoid dedifferentiation, and metastasis , 2022, Frontiers in Oncology.

[22]  Jian Wang,et al.  d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[23]  M. Rist,et al.  Hypoxic human proximal tubular epithelial cells undergo ferroptosis and elicit an NLRP3 inflammasome response in CD1c+ dendritic cells , 2022, Cell Death & Disease.

[24]  P. Puigserver,et al.  Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11 , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Rong Wang,et al.  Ginsenoside Rg1 ameliorates sepsis‐induced acute kidney injury by inhibiting ferroptosis in renal tubular epithelial cells , 2022, Journal of leukocyte biology.

[26]  Ke Peng,et al.  Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR , 2022, Frontiers in Pharmacology.

[27]  Jiaqi He,et al.  Entacapone alleviates acute kidney injury by inhibiting ferroptosis , 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  N. Agarwal,et al.  ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma , 2022, bioRxiv.

[29]  Dong-Hyun Kim,et al.  Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes , 2022, Redox biology.

[30]  Junxian Chen,et al.  Glabridin, a bioactive component of licorice, ameliorates diabetic nephropathy by regulating ferroptosis and the VEGF/Akt/ERK pathways , 2022, Molecular medicine.

[31]  F. Ai,et al.  MicroRNA-4735-3p Facilitates Ferroptosis in Clear Cell Renal Cell Carcinoma by Targeting SLC40A1 , 2022, Analytical cellular pathology.

[32]  G. Zhang,et al.  Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis , 2022, Lupus.

[33]  Di Huang,et al.  Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis , 2022, Pharmaceutical biology.

[34]  Fei Luan,et al.  Several Alkaloids in Chinese Herbal Medicine Exert Protection in Acute Kidney Injury: Focus on Mechanism and Target Analysis , 2022, Oxidative medicine and cellular longevity.

[35]  Liping Jiang,et al.  Patulin Induces Acute Kidney Injury in Mice through Autophagy-Ferroptosis Pathway. , 2022, Journal of agricultural and food chemistry.

[36]  Yan Liu,et al.  Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma , 2022, Frontiers in Immunology.

[37]  R. Yu,et al.  Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p/GPX4 axis. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[38]  S. Toyokuni,et al.  BRCA1 haploinsufficiency promotes chromosomal amplification under Fenton reaction-based carcinogenesis through ferroptosis-resistance , 2022, Redox biology.

[39]  F. Cheng,et al.  HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation , 2022, Oxidative medicine and cellular longevity.

[40]  Jing Yang,et al.  Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis , 2022, Bioengineered.

[41]  Xuejun Jiang,et al.  Ferroptosis at the intersection of lipid metabolism and cellular signaling. , 2022, Molecular cell.

[42]  Xi-Ding Yang,et al.  Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications , 2022, Frontiers in Endocrinology.

[43]  Z. Xiang,et al.  Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC , 2022, Cancer medicine.

[44]  Yaqing Wang,et al.  Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced CKD rat model , 2022, Cell death discovery.

[45]  Ximei Xu,et al.  Identification of co-expression hub genes for ferroptosis in kidney renal clear cell carcinoma based on weighted gene co-expression network analysis and The Cancer Genome Atlas clinical data , 2022, Scientific Reports.

[46]  Yajing Guo,et al.  Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis , 2022, Frontiers in Pharmacology.

[47]  Wang Yanlin,et al.  Post-treatment With Irisin Attenuates Acute Kidney Injury in Sepsis Mice Through Anti-Ferroptosis via the SIRT1/Nrf2 Pathway , 2022, Frontiers in Pharmacology.

[48]  Linbao Chen,et al.  Functions, Roles, and Biological Processes of Ferroptosis-Related Genes in Renal Cancer: A Pan-Renal Cancer Analysis , 2022, Frontiers in Oncology.

[49]  De-xiang Xu,et al.  Mitochondria-derived reactive oxygen species are involved in renal cell ferroptosis during lipopolysaccharide-induced acute kidney injury. , 2022, International immunopharmacology.

[50]  Bin Wang,et al.  Hypoxia and chronic kidney disease , 2022, EBioMedicine.

[51]  Cheng Chen,et al.  Umbelliferone delays the progression of diabetic nephropathy by inhibiting ferroptosis through activation of the Nrf-2/HO-1 pathway. , 2022, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[52]  Jinzhong Huang,et al.  Platycodin D regulates high glucose-induced ferroptosis of HK-2 cells through glutathione peroxidase 4 (GPX4) , 2022, Bioengineered.

[53]  W. Yao,et al.  Inhibition of the NADPH Oxidase Pathway Reduces Ferroptosis during Septic Renal Injury in Diabetic Mice , 2022, Oxidative medicine and cellular longevity.

[54]  A. Sanz,et al.  Ferrostatin‐1 modulates dysregulated kidney lipids in acute kidney injury , 2022, The Journal of pathology.

[55]  W. Hoy,et al.  Adenine overload induces ferroptosis in human primary proximal tubular epithelial cells , 2022, Cell Death & Disease.

[56]  E. Stone,et al.  Cyst(e)inase-Rapamycin combination induces ferroptosis in both in vitro and in vivo models of hereditary leiomyomatosis and renal cell cancer. , 2022, Molecular cancer therapeutics.

[57]  Xiaopeng Li,et al.  The multifaceted role of ferroptosis in liver disease , 2022, Cell Death & Differentiation.

[58]  YU Peng,et al.  Polydatin Attenuates Cisplatin-Induced Acute Kidney Injury by Inhibiting Ferroptosis , 2022, Oxidative medicine and cellular longevity.

[59]  Weiyu Zhang,et al.  Decreased Expression of ACADSB Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma , 2022, Frontiers in Oncology.

[60]  A. Linkermann,et al.  Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss. , 2022, Journal of the American Society of Nephrology : JASN.

[61]  Lei Wang,et al.  STEAP3 Affects Ferroptosis and Progression of Renal Cell Carcinoma Through the p53/xCT Pathway , 2022, Technology in cancer research & treatment.

[62]  Lei Wang,et al.  Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling , 2022, Technology in cancer research & treatment.

[63]  Xiaogang Li,et al.  Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential , 2022, Metabolites.

[64]  Xin Yan,et al.  Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC) , 2021, Pharmacogenomics and personalized medicine.

[65]  A. Roetto,et al.  Iron Overload, Oxidative Stress, and Ferroptosis in the Failing Heart and Liver , 2021, Antioxidants.

[66]  T. Chong,et al.  The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi‐omics study , 2021, Cancer medicine.

[67]  V. Torres,et al.  Ferroptosis Promotes Cyst Growth in Autosomal Dominant Polycystic Kidney Disease Mouse Models , 2021, Journal of the American Society of Nephrology : JASN.

[68]  Takashi Takahashi,et al.  Ferroptosis resistance determines high susceptibility of murine A/J strain to iron‐induced renal carcinogenesis , 2021, Cancer science.

[69]  Yu Rui,et al.  Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma. , 2021, Gene.

[70]  Y. Xiong,et al.  Oxalate Activates Autophagy to Induce Ferroptosis of Renal Tubular Epithelial Cells and Participates in the Formation of Kidney Stones , 2021, Oxidative medicine and cellular longevity.

[71]  Jingsai Du,et al.  Mechanisms and pharmacological applications of ferroptosis: a narrative review , 2021, Annals of translational medicine.

[72]  B. Jiang,et al.  KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. , 2021, Cancer letters.

[73]  T. Ohn,et al.  SNU-333 Cells as an Appropriate Cell Line for the Orthotopic Renal Cell Carcinoma Model , 2021, Technology in cancer research & treatment.

[74]  Ligong Lu,et al.  Tumor Microenvironment-Responsive Nanodrug for Clear-Cell Renal Cell Carcinoma Therapy via Triggering Waterfall-Like Cascade Ferroptosis. , 2021, Journal of biomedical nanotechnology.

[75]  Monica Z. Wang Protecting the kidney with probiotics , 2021, Nature Reviews Nephrology.

[76]  Yan Lin,et al.  Deficiency of the X-inactivation escaping gene KDM5C in clear cell renal cell carcinoma promotes tumorigenicity by reprogramming glycogen metabolism and inhibiting ferroptosis , 2021, Theranostics.

[77]  C. Dai,et al.  Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis , 2021, Kidney Diseases.

[78]  H. Reich,et al.  IgA Nephropathy: Core Curriculum 2021. , 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[79]  Ben Xu,et al.  Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene , 2021, Translational cancer research.

[80]  Xiaofen Xu,et al.  Kaempferol Ameliorates Oxygen-Glucose Deprivation/Reoxygenation-Induced Neuronal Ferroptosis by Activating Nrf2/SLC7A11/GPX4 Axis , 2021, Biomolecules.

[81]  A. Strasser,et al.  Molecular mechanisms of cell death in neurological diseases , 2021, Cell Death & Differentiation.

[82]  B. Brüne,et al.  Iron-Bound Lipocalin-2 Protects Renal Cell Carcinoma from Ferroptosis , 2021, Metabolites.

[83]  L. Zhuang,et al.  Ferroptosis, radiotherapy, and combination therapeutic strategies , 2021, Protein & Cell.

[84]  T. Yoo,et al.  Characterization of ferroptosis in kidney tubular cell death under diabetic conditions , 2021, Cell Death & Disease.

[85]  Ying‐Kai Hong,et al.  A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma , 2021, BMC cancer.

[86]  B. Stockwell,et al.  Ferroptosis: mechanisms, biology and role in disease , 2021, Nature Reviews Molecular Cell Biology.

[87]  Xuan Li,et al.  Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation , 2021, Free radical research.

[88]  Yumei Fan,et al.  Nuciferine protects against folic acid‐induced acute kidney injury by inhibiting ferroptosis , 2021, British journal of pharmacology.

[89]  Lei Chen,et al.  Acyl-CoA Thioesterase 8 and 11 as Novel Biomarkers for Clear Cell Renal Cell Carcinoma , 2020, Frontiers in Genetics.

[90]  C. Rudin,et al.  Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer , 2020, Cell reports.

[91]  Zhongming Wu,et al.  Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. , 2020, Free radical biology & medicine.

[92]  T. Efferth,et al.  Artesunate Inhibits Growth of Sunitinib-Resistant Renal Cell Carcinoma Cells through Cell Cycle Arrest and Induction of Ferroptosis , 2020, Cancers.

[93]  W. Xue,et al.  SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis , 2020, Acta pharmaceutica Sinica. B.

[94]  Yong Gu,et al.  Tocilizumab mimotope alleviates kidney injury and fibrosis by inhibiting IL-6 signaling and ferroptosis in UUO model. , 2020, Life sciences.

[95]  Qiuhua Cao,et al.  Ferroptosis involves in renal tubular cell death in diabetic nephropathy. , 2020, European journal of pharmacology.

[96]  P. Clemons,et al.  Plasticity of ether lipids promotes ferroptosis susceptibility and evasion , 2020, Nature.

[97]  Zhihua Chen,et al.  Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases , 2020, Frontiers in Cellular Neuroscience.

[98]  B. Brüne,et al.  Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis , 2020, Redox biology.

[99]  Ying Yao,et al.  XJB-5-131 inhibited ferroptosis in tubular epithelial cells after ischemia−reperfusion injury , 2020, Cell Death & Disease.

[100]  L. Birnbaumer,et al.  Quercetin alleviates acute kidney injury by inhibiting ferroptosis , 2020, Journal of advanced research.

[101]  Yuehua Wu,et al.  Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma , 2020, Acta Pharmacologica Sinica.

[102]  B. Stockwell,et al.  Emerging Mechanisms and Disease Relevance of Ferroptosis. , 2020, Trends in cell biology.

[103]  Na Guo Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma , 2020, Translational cancer research.

[104]  P. Lei,et al.  The pathological role of ferroptosis in ischemia/reperfusion-related injury , 2020, Zoological research.

[105]  Xiaohua Song,et al.  Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases , 2020, Frontiers in Neuroscience.

[106]  Zhe Chen,et al.  Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway , 2020, Frontiers in Oncology.

[107]  Z. Peng,et al.  Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis , 2019, Oxidative medicine and cellular longevity.

[108]  D. Hsu,et al.  The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma. , 2019, Cell reports.

[109]  Yan Song,et al.  The role of ferroptosis in digestive system cancer. , 2019, Oncology letters.

[110]  X. Ao,et al.  Molecular mechanisms of ferroptosis and its role in cancer therapy , 2019, Journal of cellular and molecular medicine.

[111]  John G Doench,et al.  A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis , 2019, Nature Communications.

[112]  M. Diederich,et al.  Redox biology of regulated cell death in cancer: A focus on necroptosis and ferroptosis. , 2019, Free radical biology & medicine.

[113]  P. Kochanek,et al.  Ferroptosis Contributes to Neuronal Death and Functional Outcome After Traumatic Brain Injury* , 2019, Critical care medicine.

[114]  Changlian Zhu,et al.  The Potential Role of Ferroptosis in Neonatal Brain Injury , 2019, Front. Neurosci..

[115]  F. Zhang,et al.  Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion , 2019, Cell Death & Differentiation.

[116]  G. Schley,et al.  Lipid Peroxidation Drives Renal Cyst Growth In Vitro through Activation of TMEM16A. , 2019, Journal of the American Society of Nephrology : JASN.

[117]  Austin Carter,et al.  Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories , 2018, The Lancet.

[118]  Guo-yi Gao,et al.  Inhibition of ferroptosis attenuates tissue damage and improves long‐term outcomes after traumatic brain injury in mice , 2018, CNS neuroscience & therapeutics.

[119]  D. Swinkels,et al.  Publisher Correction: Tubular iron deposition and iron handling proteins in human healthy kidney and chronic kidney disease , 2018, Scientific Reports.

[120]  G. Aldini Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds , 2018, Free Radical Biology and Medicine.

[121]  J. Wohlschlegel,et al.  Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction , 2018, Cancer science.

[122]  D. Felsher,et al.  The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma , 2018, Oncogene.

[123]  S. Woo,et al.  Corosolic Acid Induces Non-Apoptotic Cell Death through Generation of Lipid Reactive Oxygen Species Production in Human Renal Carcinoma Caki Cells , 2018, International journal of molecular sciences.

[124]  S. Lipton,et al.  Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.

[125]  Hao Wang,et al.  Antioxidants Mediate Both Iron Homeostasis and Oxidative Stress , 2017, Nutrients.

[126]  Jodie L Babitt,et al.  Overview of iron metabolism in health and disease , 2017, Hemodialysis international. International Symposium on Home Hemodialysis.

[127]  C. Culmsee,et al.  BID links ferroptosis to mitochondrial cell death pathways , 2017, Redox biology.

[128]  Ahmed Hamaï,et al.  [Autophagy and iron homeostasis]. , 2017, Medecine sciences : M/S.

[129]  H. Pavenstädt,et al.  Differential effects of anoctamins on intracellular calcium signals , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[130]  R. Keep,et al.  Brain iron overload following intracranial haemorrhage , 2016, Stroke and Vascular Neurology.

[131]  S. Feske,et al.  Store-operated Ca2+ entry regulates Ca2+-activated chloride channels and eccrine sweat gland function. , 2016, The Journal of clinical investigation.

[132]  L. Galluzzi,et al.  Regulated cell death and adaptive stress responses , 2016, Cellular and Molecular Life Sciences.

[133]  D. Tang,et al.  Ferroptosis: process and function , 2016, Cell Death and Differentiation.

[134]  A. Massie,et al.  Main path and byways: non‐vesicular glutamate release by system xc− as an important modifier of glutamatergic neurotransmission , 2015, Journal of neurochemistry.

[135]  W. Gu,et al.  Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses , 2015, Cell cycle.

[136]  G. Superti-Furga,et al.  Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death , 2015, ACS chemical biology.

[137]  T. Masuyama,et al.  Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease , 2015, Hypertension Research.

[138]  G. Schley,et al.  Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion. , 2014, Journal of the American Society of Nephrology : JASN.

[139]  T. Tamaki,et al.  Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction , 2014, PloS one.

[140]  C. Tandon,et al.  Nephrolithiasis: Molecular Mechanism of Renal Stone Formation and the Critical Role Played by Modulators , 2013, BioMed research international.

[141]  Richard L. Frock,et al.  Programmed Cell Death in Animal Development and Disease , 2011, Cell.

[142]  A. Žák,et al.  Fatty acids as biocompounds: their role in human metabolism, health and disease--a review. Part 1: classification, dietary sources and biological functions. , 2011, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[143]  I. Vrabas,et al.  Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. , 2010, Metabolism: clinical and experimental.

[144]  Min Ho Tak,et al.  TMEM16A confers receptor-activated calcium-dependent chloride conductance , 2008, Nature.

[145]  R. Moon The Wnt/β-catenin Pathway , 2003, Science's STKE.

[146]  William C Hahn,et al.  Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. , 2003, Cancer cell.

[147]  B. Magenheimer,et al.  Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease. , 2002, Journal of the American Society of Nephrology : JASN.

[148]  T. Hosokawa,et al.  Iron deposition in renal biopsy specimens from patients with kidney diseases. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[149]  D. Harris,et al.  Iron accumulation in human chronic renal disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[150]  M. Paller Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. , 1988, The American journal of physiology.

[151]  L. Woodard,et al.  Tissue Culture Models of AKI: From Tubule Cells to Human Kidney Organoids , 2022 .